StockNews.com began coverage on shares of China Pharma (NYSE:CPHI – Get Free Report) in a research note issued to investors on Saturday. The brokerage set a “hold” rating on the stock.
China Pharma Stock Performance
CPHI stock opened at $0.25 on Friday. China Pharma has a 1 year low of $0.17 and a 1 year high of $1.21. The stock’s 50 day moving average price is $0.21 and its 200 day moving average price is $0.27. The company has a quick ratio of 0.24, a current ratio of 0.84 and a debt-to-equity ratio of 0.19.
China Pharma (NYSE:CPHI – Get Free Report) last announced its earnings results on Wednesday, August 14th. The company reported ($0.09) earnings per share for the quarter. The firm had revenue of $0.93 million during the quarter. China Pharma had a negative net margin of 70.47% and a negative return on equity of 60.19%.
About China Pharma
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Stories
- Five stocks we like better than China Pharma
- Stock Splits, Do They Really Impact Investors?
- The Outlook for Interest Rate Cuts Got Blown Out of the Water
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 High-Risk, High-Reward Micro-Cap Stocks You Shouldn’t Ignore
- Financial Services Stocks Investing
- 3 Bargain Stocks Positioned for Gains After Missing 2024’s Rally
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
